Valuation : InterCure Ltd.

Market Cap 191M 0 165M 156M 141M 265M 18.27B 267M 1.85B 712M 9.29B 718M 702M 29.36B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 328M 0 282M 267M 242M 454M 31.29B 457M 3.17B 1.22B 15.92B 1.23B 1.2B 50.3B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day-1.41%
1 week-0.49%
Current month-10.03%
1 month+10.40%
3 months+25.31%
6 months+28.81%
Current year-0.25%
1 week 1,597
Extreme 1597
1,702
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,783.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 66 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Other

Chief Financial Officer

539,947 0.9874%
3/18/26 Other

Director

19,046 0.0348%
3/18/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-0.49%-40.46%-48.25% 62.82M
+0.70%-1.37%+15.20%+171.70% 350M
-2.04%-9.43%-37.12%-43.08% 150M
+1.79%0.00%+15.70%+103.06% 140M
+12.09%+9.68%-26.09%-60.16% 92.49M
Average +2.23%-1.30%-14.55%+24.65% 158.91M
Weighted average by Cap. +1.53%-1.71%-3.78%+74.76%

Financials

2024 2025
Net sales 239M 0 206M 195M 177M 331M 22.82B 333M 2.31B 890M 11.61B 897M 877M 36.68B 270M 0 233M 220M 200M 375M 25.81B 377M 2.62B 1.01B 13.13B 1.01B 992M 41.5B
Net income -67.8M -0 -58.41M -55.31M -50.13M -94.05M -6.48B -94.53M -657M -253M -3.3B -255M -249M -10.41B -35.71M -0 -30.77M -29.13M -26.41M -49.54M -3.41B -49.79M -346M -133M -1.74B -134M -131M -5.48B
Net Debt 133M 0 114M 108M 98.17M 184M 12.68B 185M 1.29B 495M 6.45B 499M 488M 20.39B 136M 0 117M 111M 101M 189M 13.03B 190M 1.32B 508M 6.63B 512M 501M 20.94B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-09-10 ILA 1,614.00 -1.41% 9,949
26-09-09 ILA 1,637.00 -2.79% 8,278
26-09-08 ILA 1,684.00 +0.90% 6,257
26-09-07 ILA 1,669.00 +0.42% 12,751
26-09-04 ILA 1,662.00 +2.47% 5,273
  1. Stock Market
  2. Stocks
  3. INCR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!